Skip to content

Guided Self-Help Treatment for Binge Eating Disorder

Binge Eating Self-Guided Treatment (BEST)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00158340
Acronym
BEST
Enrollment
284
Registered
2005-09-12
Start date
2004-08-31
Completion date
2008-07-31
Last updated
2011-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating Disorders, Bulimia

Keywords

Binge Eating, Overeating, Compulsive Eating, Hyperphagia

Brief summary

This study will determine the effectiveness of guided self-help treatment in treating individuals with binge eating disorder (BED).

Detailed description

Binge eating disorder (BED) is a serious condition characterized by compulsive overeating and feelings of powerlessness. The condition often has a negative impact on both physical and emotional health. This study will examine ways to help people determine whether they have BED and will test whether guided self-help (GSH) treatment is effective in treating BED. Participants will be randomly assigned to receive either GSH treatment or usual clinical care (which may include general support and talk therapy) for 3 months. The GSH treatment is a cognitive behavioral therapy-based program that will be administered over 8 sessions. Participants receiving GSH will be given a book that focuses on dealing with BED; they will also meet with a therapist regularly to have their progress monitored. The Eating Disorders Examination (EDE), self-reports, questionnaires, and surveys will be used to assess participants. Assessments will be conducted at study entry, at Weeks 2 and 4 of the treatment, at the end of the treatment, and at 6 and 12 months post-treatment.

Interventions

BEHAVIORALGuided self-help cognitive behavioral therapy (CBT)

Participants receive eight sessions of guided self-help CBT.

Control group participants receive treatment as usual.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of binge eating disorder (BED) bulimia nervosa (BN), or spectrum BN, defined as recurrent binge eating at least once a week for 3 months * Body mass index (BMI) between 18 and 45 * Continuous membership in the Kaiser Permanente Northwest Division for at least 12 months prior to study entry

Exclusion criteria

* Diagnosis of anorexia nervosa or psychotic disorder * Significant organic brain syndromes, retardation, pervasive developmental disorder, or autism * At risk for suicide * Pregnancy

Design outcomes

Primary

MeasureTime frame
Frequency of binge eatingMeasured at post-treatment, Week 12, Month 6, and Year 1

Secondary

MeasureTime frame
Frequency of inappropriate compensatory behaviors, dietary restraint, over-valuation of weight/shape, functional impairment, self-esteem, and social impairmentMeasured at post-treatment, Week 12, Month 6, and Year 1
Body weightMeasured at post-treatmentand Year 1

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026